Imfinzi (durvalumab) is used to treat
Lung Cancer. Imfinzi is a monocolonal antibody, which works by helping the immune system target cancer cells in the body. The most common version of Imfinzi is a 10ml vial. It is also available as a 2.4ml vial. There are currently no generic alternatives for Imfinzi. It is covered by some Medicare and insurance plans.